Skip to main content
TipRanks
Go Ultimate75% OFF

Wai Chun Bio-Technology Ltd. (0660) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Wai Chun Bio-Technology Ltd. has a market cap or net worth of HKD 165.25M. The enterprise value is HKD 198.91M.

Market Cap
HKD 165.25M
Enterprise Value
HKD 198.91M

Share Statistics

Wai Chun Bio-Technology Ltd. has 384,309,780 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
384,309,780
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Wai Chun Bio-Technology Ltd.’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 16.46%.

Return on Equity (ROE)
0.16
Return on Assets (ROA)
-0.07
Return on Invested Capital (ROIC)
16.46%
Return on Capital Employed (ROCE)
-0.09
Revenue Per Employee
6.18M
Profits Per Employee
-239.72K
Employee Count
61
Asset Turnover
1.76
Inventory Turnover
6.04

Valuation Ratios

The current PE Ratio of Wai Chun Bio-Technology Ltd. is -11.11. Wai Chun Bio-Technology Ltd.’s PEG ratio is -0.07.

PE Ratio
-11.11
PS Ratio
0.29
PB Ratio
-1.20
Price to FCF
-35.30
Price to Operating Cash Flow
3.60
PEG Ratio
-0.07

Income Statement

In the last 12 months, Wai Chun Bio-Technology Ltd. had revenue of 377.17M and earned -14.62M in profits. Earnings per share was -0.08.

Revenue
377.17M
Gross Profit
36.00M
Operating Income
5.36M
Pretax Income
-8.93M
Net Income
-14.62M
EBITDA
17.90M
Earnings Per Share (EPS)
-0.08

Cash Flow

In the last 12 months, operating cash flow was 7.74B and capital expenditures -719.91M, giving a free cash flow of 7.02B billion.

Operating Cash Flow
7.74B
Free Cash Flow
7.02B
Free Cash Flow per Share
-0.03

Dividends & Yields

Wai Chun Bio-Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.83%
Earnings Yield
-8.99%

Stock Price Statistics

Beta
1.26
52-Week Price Change
119.39%
50-Day Moving Average
0.43
200-Day Moving Average
0.47
Relative Strength Index (RSI)
51.44
Average Volume (3m)
310.17K

Important Dates

Wai Chun Bio-Technology Ltd. upcoming earnings date is Sep 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Sep 24, 2027
Ex-Dividend Date
―

Financial Position

Wai Chun Bio-Technology Ltd. as a current ratio of 0.39, with Debt / Equity ratio of -104.51%

Current Ratio
0.39
Quick Ratio
0.18
Debt to Market Cap
3.98
Net Debt to EBITDA
4.95
Interest Coverage Ratio
0.39

Taxes

In the past 12 months, Wai Chun Bio-Technology Ltd. has paid 1.77M in taxes.

Income Tax
1.77M
Effective Tax Rate
-0.20

Enterprise Valuation

Wai Chun Bio-Technology Ltd. EV to EBITDA ratio is 19.96, with an EV/FCF ratio of -63.66.

EV to Sales
0.52
EV to EBITDA
19.96
EV to Free Cash Flow
-63.66
EV to Operating Cash Flow
13.97

Balance Sheet

Wai Chun Bio-Technology Ltd. has HKD 16.66B in cash and marketable securities with HKD 12.34B in debt, giving a net cash position of HKD 4.32B billion.

Cash & Marketable Securities
HKD 16.66B
Total Debt
HKD 12.34B
Net Cash
HKD 4.32B
Net Cash Per Share
HKD 11.24
Tangible Book Value Per Share
―

Margins

Gross margin is 8.89%, with operating margin of 1.17%, and net profit margin of -1.21%.

Gross Margin
8.89%
Operating Margin
1.17%
Pretax Margin
-0.18%
Net Profit Margin
-1.21%
EBITDA Margin
2.63%
EBIT Margin
1.28%

Analyst Forecast

The average price target for Wai Chun Bio-Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
66.75%
EPS Growth Forecast
87.02%

Scores

Smart Score
7
AI Score
―